国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Pseudoalteromonas haloplanktis Exodeoxyribonuclease 7 small subunit (xseB) CSB-YP668241PTP
CSB-EP668241PTP
CSB-BP668241PTP
CSB-MP668241PTP
CSB-EP668241PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Valine--tRNA ligase (valS), partial CSB-YP668242PTP
CSB-EP668242PTP
CSB-BP668242PTP
CSB-MP668242PTP
CSB-EP668242PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Dephospho-CoA kinase (coaE) CSB-YP668243PTP
CSB-EP668243PTP
CSB-BP668243PTP
CSB-MP668243PTP
CSB-EP668243PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP668244PTP
CSB-EP668244PTP
CSB-BP668244PTP
CSB-MP668244PTP
CSB-EP668244PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Adenylosuccinate synthetase 2 (purA2) CSB-YP668245PTP
CSB-EP668245PTP
CSB-BP668245PTP
CSB-MP668245PTP
CSB-EP668245PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Uridylate kinase (pyrH) CSB-YP668246PTP
CSB-EP668246PTP
CSB-BP668246PTP
CSB-MP668246PTP
CSB-EP668246PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Xaa-Pro dipeptidase (pepQ) CSB-YP668247PTP
CSB-EP668247PTP
CSB-BP668247PTP
CSB-MP668247PTP
CSB-EP668247PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Chorismate synthase (aroC) CSB-YP668248PTP
CSB-EP668248PTP
CSB-BP668248PTP
CSB-MP668248PTP
CSB-EP668248PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis UPF0250 protein PSHAa1021 (PSHAa1021) CSB-YP668249PTP
CSB-EP668249PTP
CSB-BP668249PTP
CSB-MP668249PTP
CSB-EP668249PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Imidazolonepropionase (hutI) CSB-YP668250PTP
CSB-EP668250PTP
CSB-BP668250PTP
CSB-MP668250PTP
CSB-EP668250PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Guanylate kinase (gmk) CSB-YP668251PTP
CSB-EP668251PTP
CSB-BP668251PTP
CSB-MP668251PTP
CSB-EP668251PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis 30S ribosomal protein S14 (rpsN) CSB-YP668252PTP
CSB-EP668252PTP
CSB-BP668252PTP
CSB-MP668252PTP
CSB-EP668252PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis 30S ribosomal protein S11 (rpsK) CSB-YP668253PTP
CSB-EP668253PTP
CSB-BP668253PTP
CSB-MP668253PTP
CSB-EP668253PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis ATP synthase epsilon chain (atpC) CSB-YP668254PTP
CSB-EP668254PTP
CSB-BP668254PTP
CSB-MP668254PTP
CSB-EP668254PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis ATP synthase subunit delta (atpH) CSB-YP668255PTP
CSB-EP668255PTP
CSB-BP668255PTP
CSB-MP668255PTP
CSB-EP668255PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis tRNA modification GTPase MnmE (mnmE) CSB-YP668256PTP
CSB-EP668256PTP
CSB-BP668256PTP
CSB-MP668256PTP
CSB-EP668256PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis Outer-membrane lipoprotein LolB (lolB) CSB-YP668257PTP
CSB-EP668257PTP
CSB-BP668257PTP
CSB-MP668257PTP
CSB-EP668257PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis UPF0060 membrane protein PSHAa1175 (PSHAa1175), partial CSB-YP668258PTP1
CSB-EP668258PTP1
CSB-BP668258PTP1
CSB-MP668258PTP1
CSB-EP668258PTP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis 3,4-dihydroxy-2-butanone 4-phosphate synthase (ribB) CSB-YP668259PTP
CSB-EP668259PTP
CSB-BP668259PTP
CSB-MP668259PTP
CSB-EP668259PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas haloplanktis 50S ribosomal protein L20 (rplT) CSB-YP668260PTP
CSB-EP668260PTP
CSB-BP668260PTP
CSB-MP668260PTP
CSB-EP668260PTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>